ARTICLE | Clinical News
Dapsone: Halted Phase I trial
April 2, 2001 7:00 AM UTC
Immune Network Ltd. (IMMKF; CDNX:IMM), Vancouver, B.C. Product: Dapsone Business: Neurological Therapeutic category: Immune modulation Target: Inflammatory enzymes Description: Anti-inflammatory sulfo...